Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03860337
Other study ID # SAU 01615
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 13, 2019
Est. completion date June 19, 2019

Study information

Verified date September 2019
Source Newcastle University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will investigate the effect of an extract of brown seaweed, called alginate, on fat digestion. The extract has been cooked into sausages and the alginate sausages will be compared to the same sausages that do not contain alginate. People taking part in the study will come to the study centre twice. Once to have the alginate sausage meal or the normal sausage meal and on the second visit they will have the other meal so then end up having had both types of sausages. The level of fat in their blood will be monitored over the four hours after the meal. The rate and amount of fat that moves into the blood after a meal is an indication of the amount of fat digestion. We believe that less fat will be digested and move into the blood when the volunteers eat the alginate sausages compared to the normal sausages.


Description:

Alginate is an extract of brown seaweed and has been shown to reduce lipase activity in vitro. Lipase is a valid target for anti-obesity products as shown by the pharmaceutical drug orlistat which targets the same enzyme. Reducing the amount of lipase activity will reduce the amount of triacylglycerol (TAG) that will be digested and therefore absorbed and will be seen as a reduction in the level of circulating TAG in the blood. Adding alginate to a range of food products that are simple to include into the diet could help with the management of obesity. In this study, sausages containing alginate have been manufactured for us along with matched control sausage. The circulating TAG in the blood will be measured via fingerpick blood samples every 30 minutes for four hours after the volunteers have eaten either alginate sausages or normal sausages. The volunteers will come for two visits and consume the other sausage meal at the second so they will have had both types of sausage.


Recruitment information / eligibility

Status Completed
Enrollment 15
Est. completion date June 19, 2019
Est. primary completion date June 19, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

-

Exclusion Criteria:

- pregnant or lactating.

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Alginate Sausage
Alginate sausage
Other:
Control Sausage
Control Sausage

Locations

Country Name City State
United Kingdom Newcastle University Newcastle Tyne And Wear

Sponsors (1)

Lead Sponsor Collaborator
Newcastle University

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Concentration of circulating TAG in blood mmol/L 4 hours after the test meal
Secondary Concentration of circulating glucose in blood mmol/L 4 hours after the test meal